切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - CETP - calcium uptake - Deubiquitinating enzymes (DUBs) - 5-HT receptor

10 件产品

每页
清除全部
  1. Spautin-1
    B5873 Spautin-1
     1 Citation
    Target: Deubiquitinating enzymes (DUBs)|Autophagy
    Summary: 自噬抑制剂
      ≥13.5 mg/mL
      insoluble in H2O
  2. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O
  3. ML-323
    B1317 ML-323
    Target: Deubiquitinating enzymes (DUBs)
    Summary: USP1-UAF1抑制剂
      ≥15.05 mg/mL
      ≥2.25 mg/mL
  4. Ranolazine
    A8510 Ranolazine
     1 Citation
    中文名: 雷诺嗪
    Target: calcium uptake
    Summary: 抗缺血
      ≥17.4 mg/mL
      insoluble in H2O
  5. PR-619
    A8212 PR-619
    Target: Deubiquitinating enzymes (DUBs)
    Summary: 去泛素化酶(DUBs)抑制剂
      ≥11.15 mg/mL
      insoluble in H2O
  6. NSC 687852 (b-AP15)
    A4453 NSC 687852 (b-AP15)
    Target: Deubiquitinating enzymes (DUBs)
    Summary: 19S调节颗粒抑制剂
      ≥20.95 mg/mL
      insoluble in H2O
  7. Vialinin A
    A4429 Vialinin A
    Target: Deubiquitinating enzymes (DUBs)|IL Receptors|CCL2
    Summary: USP/IsoT/UCH-L1 DUB抑制剂
      Soluble in DMSO
  8. Quetiapine
    A3744 Quetiapine
    中文名: 喹硫平
    Target: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptor
    Summary: 多巴胺受体拮抗剂
      ≥19.18 mg/mL
      insoluble in H2O
  9. Evacetrapib (LY2484595)
    A4377 Evacetrapib (LY2484595)
    Target: CETP
    Summary: 强效的CETP选择性抑制剂
      ≥32.1 mg/mL
      insoluble in H2O
  10. Anacetrapib (MK-0859)
    A4375 Anacetrapib (MK-0859)
     1 Citation
    中文名: 安塞曲匹
    Target: CETP
    Summary: RhCETP/突变型 CETP(C13S) 抑制剂
      ≥31.9 mg/mL
      insoluble in H2O

10 件产品

每页